SCHEMBL5567669

SCHEMBL5567669

[c]1oc2ccccc2c1-c1ncccn1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.36
ALDH1A1 P00352 3/20 0.36
MAPT P10636 4/20 0.35
HPGD P15428 2/20 0.35
HSD17B10 Q99714 2/20 0.35
GAA P10253 1/20 0.35
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
NPC1 O15118 2/20 0.33
HIF1A Q16665 1/20 0.33
BRD4 O60885 1/20 0.32
HDAC8 Q9BY41 1/20 0.31
LMNA P02545 1/20 0.31
TSHR P16473 1/20 0.31
CYP19A1 P11511 1/20 0.30
TP53 P04637 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6430073 0.85 SMN1; SMN2 (0.31) SMN1; SMN2
SCHEMBL646759 0.81 KDM4E (0.45) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL21296037 0.76 NOTUM (0.40) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL3028469 0.75 BRD4 (0.40) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL7808907 0.74 KDM4E (0.42) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL3685297 0.74 ADRA2A (0.45) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL2958656 0.74 CA1 (0.36) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL21295803 0.72 ALDH1A1 (0.45) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL18957373 0.72 DHODH (0.34)
SCHEMBL4960655 0.69 ADORA3 (0.43) KDM4EALDH1A1MAPTHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11072573-B2 Binaphthyl compounds REUTER CHEMISCHE APPARATEBAU E.K. (DE) 2021-07-27 US disclosed
US-20200354299-A1 BINAPHTHYL COMPOUNDS REUTER CHEMISCHE APPARATEBAU E.K. (DE) 2020-11-12 US disclosed
EP-3676239-A1 BINAPHTHYL COMPOUNDS Reuter Chemische Apparatenbau e.K. (DE) 2020-07-08 EP disclosed
WO-2019043060-A1 BINAPHTHYL COMPOUNDS REUTER CHEMISCHE APPARATEBAU KG (DE) 2019-03-07 WO disclosed
EP-1758911-A1 1-HETEROCYCLYL-1,5-DIHYDRO-PYRIDO[3,2-B]INDOL-2-ONES Tibotec Pharmaceuticals Ltd. (IE) 2007-03-07 EP disclosed
WO-2005111047-A1 1-HETEROCYCLYL-1,5-DIHYDRO-PYRIDO[3,2-B]INDOL-2-ONES TIBOTEC PHARMACEUTICALS LTD. (IE) 2005-11-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200354299-A1 BINAPHTHYL COMPOUNDS UACA, C9, C1S KDM4E 1333/4885ALDH1A1 1476/4885MAPT 4050/4885
US-11072573-B2 Binaphthyl compounds UACA, C9, C1S KDM4E 1333/4885ALDH1A1 1476/4885MAPT 4050/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.